Get started
Award

R01 DK103616

Funded outputs count: 64
Funder award ID: R01 DK103616
OpenAlex ID: G2941677115
NF Erythroid 2-Related Factor 2 Peroxisome Proliferator-Activated Receptor-γ Crosstalk
2025 · John D. Imig · Kidney360
EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage
2025 · Abhishek Mishra, Marcus de Bourg, et al. · Biomolecules
PDF
Dual acting inhibitor of soluble epoxide hydrolase and Cyclooxygenase-2, attenuates glomerular injury in renal hypoplasia mice
2025 · Md Abdul Hye Khan, Samaneh Goorani, et al. · European Journal of Pharmacology · 2
Kidney Injury by Unilateral Ureteral Obstruction in Mice Lacks Sex Differences
2024 · Samaneh Goorani, Abdul Hye Khan, et al. · Kidney & Blood Pressure Research · 5
Changes in carotid arterial wall viscosity and carotid arterial stiffness in type 2 diabetes patients
2023 · Frédéric Roca, Louise Zmuda, et al. · Atherosclerosis · 3
Salt-sensitive hypertension after reversal of unilateral ureteral obstruction
2023 · John D. Imig, Md Abdul Hye Khan, et al. · Biochemical Pharmacology · 7
Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors
2022 · Sandra Codony, José M. Entrena, et al. · Journal of Medicinal Chemistry · 21
Osteopontin Regulates Phosphate Solubility to Prevent Mineral Aggregates in CKD
2022 · John D. Imig · Kidney360 · 4
A New Family of Subnanomolar inhibitors of Soluble Epoxide Hydrolase
2022 · Carmen Escolano, Andrea Bagan, et al. · The FASEB Journal
Soluble Epoxide Hydrolase Inhibitors: Design, Synthesis, in vitro Profiling and in vivo Evaluation in Murine Models of Pain
2022 · Santiago Vázquez, Sandra Codony, et al. · The FASEB Journal
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease
2022 · Sandra Codony, Caterina Pont, et al. · Journal of Medicinal Chemistry · 58
PDF
2-(Piperidin-4-yl)acetamides as Potent Inhibitors of Soluble Epoxide Hydrolase with Anti-Inflammatory Activity
2021 · Juan Martín-López, Sandra Codony, et al. · Pharmaceuticals · 7
PDF
Epoxylipids and soluble epoxide hydrolase in heart diseases
2021 · John D. Imig, Ludek Cervenka, et al. · Biochemical Pharmacology · 27
Replacement of Lost Substance P Reduces Fibrosis in the Diabetic Heart by Preventing Adverse Fibroblast and Macrophage Phenotype Changes
2021 · Alexander Widiapradja, Ainsley O. Kasparian, et al. · Cells · 26
PDF
Multi-Target Drugs for Kidney Diseases
2021 · John D. Imig, Daniel Merk, et al. · Kidney360 · 19
Multitarget molecule, PTUPB, to treat diabetic nephropathy in rats
2021 · Md. Abdul Hye Khan, Sung Hee Hwang, et al. · British Journal of Pharmacology · 13
From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis
2021 · Sandra Codony, Carla Calvó-Tusell, et al. · Journal of Medicinal Chemistry · 29
PDF
Multi-Target Approaches in Metabolic Syndrome
2021 · Felix F. Lillich, John D. Imig, et al. · Frontiers in Pharmacology · 148
PDF
Adrenic Acid-Derived Epoxy Fatty Acids Are Naturally Occurring Lipids and Their Methyl Ester Prodrug Reduces Endoplasmic Reticulum Stress and Inflammatory Pain
2021 · Nalin Singh, Bogdan Barnych, et al. · ACS Omega · 29
PDF
Editorial: Renal Function in Acute and Chronic Kidney Diseases
2020 · John D. Imig, Md Abdul Hye Khan, et al. · Frontiers in Physiology · 3
PDF
2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis
2020 · Sandra Codony, Eugènia Pujol, et al. · Journal of Medicinal Chemistry · 27
PDF
Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics
2020 · John D. Imig, Wojciech K. Jankiewicz, et al. · Hypertension · 24
PDF
Vascular Lipidomic Profiling of Potential Endogenous Fatty Acid PPAR Ligands Reveals the Coronary Artery as Major Producer of CYP450-Derived Epoxy Fatty Acids
2020 · Matthew L. Edin, Fred B. Lih, et al. · Cells · 18
PDF
The effect of compound DM509 on kidney fibrosis in the conditions of the experimental model
2020 · A. Stavniichuk, O. Savchuk, et al. · Bulletin of Taras Shevchenko National University of Kyiv Series “Psychology” · 4
A sorafenib-induced model of glomerular kidney disease
2020 · A. Stavniichuk, O. Savchuk, et al. · Bulletin of Taras Shevchenko National University of Kyiv Series “Psychology” · 5
Year
Topic